Pancreatic cancer is a serious and often deadly form of cancer that develops in the pancreas, an organ located behind the stomach1. Fewer than 20 percent of patients have a localized and potentially curable tumor at diagnosis, and the overall 5-year survival rate is less than 5 percent2. Early detection is crucial for improving outcomes, but pancreatic cancer is notoriously difficult to diagnose in its early stages. Magnetic resonance imaging (MRI) is important in diagnosing and staging pancreatic cancer.
MRI is a highly effective and noninvasive imaging method that relies on strong magnetic fields and radio waves to produce detailed images of internal body structures3. It operates by aligning the body's hydrogen atoms with a magnetic field and then disrupting this alignment using radiofrequency pulses. Once the pulses cease, the atoms realign, releasing signals to create precise images4. Unlike X-rays and CT scans, MRI does not involve ionizing radiation, making it a safer choice for multiple scans.
MRI is crucial in detecting pancreatic cancer, particularly for early detection and differentiating between benign and malignant tumors.
MRI is vital for early detection of pancreatic cancer for several reasons:
MRI is highly effective in distinguishing between benign and malignant pancreatic tumors.
MRI offers several advantages for detecting pancreatic cancer. MRI provides detailed images of the pancreas and surrounding tissues without using ionizing radiation or requiring invasive procedures. A particular type of MRI called magnetic resonance cholangiopancreatography (MRCP) can image the pancreatic and bile ducts where tumors often form12. Furthermore, MRI can detect pancreatic tumors as small as a few millimeters in size, which is crucial for early diagnosis13.
These advantages make MRI a valuable tool alongside endoscopic ultrasound for pancreatic screening and diagnosis.
The procedure for an MRI is very straightforward. However, there are general rules to follow14.
Before the MRI: Leave all jewelry and metal objects at home. You can generally eat and drink as usual unless specifically instructed otherwise. If your MRI involves contrast agents or sedation, you may be asked to avoid eating or drinking for a few hours before the procedure.
You'll be asked to change into a hospital gown and remove any clothing with metal components, including underwire bras. Inform your doctor about any medical conditions, implants, or claustrophobia. Bring a list of your current medications. Avoid applying deodorants, antiperspirants, perfumes, or body lotions before the exam, as they may contain metals that interfere with the magnetic field.
During the MRI: The procedure typically lasts 30-60 minutes. You'll lie on a table that slides into a large, tube-shaped machine. The machine makes loud noises, so earplugs or headphones may be provided. It's crucial to remain as still as possible during the scan to ensure clear images. You'll be able to communicate with the technologist through an intercom system and will have a call button if you need assistance.
After the MRI: After the scan, you can resume your normal activities unless sedation is used. Your doctor will contact you with the results within a week or so.
For more information on how to prepare for an MRI, you can read this article here.
MRI uses powerful magnets and radio waves to create detailed images, CT scans use ionizing radiation, and PET scans expose you to radioactive tracers15,16.
MRI, CT, and PET scans each have strengths and limitations when detecting pancreatic cancer.
Pros:
Cons:
Pros:
Cons:
Pros:
Cons:
Often, a combination of these imaging methods may be used for comprehensive evaluation and accurate diagnosis of pancreatic cancer.
MRI is highly sensitive (81-99 percent) for detecting pancreatic tumors, especially small lesions. It is beneficial for characterizing cystic lesions5.
Yes, MRI can detect small tumors (as small as a few millimeters) that other imaging methods might miss13.
The cost of an MRI varies depending on location, insurance, the type of MRI, and potential hidden costs. However, at Ezra, a full-body scan, which includes imaging of 13 organs, costs a fixed amount. This consists of the scan and a follow-up with a medical practitioner to discuss your results. A full-body scan at Ezra will cost $2395.
MRI is necessary for detecting pancreatic cancer because it produces high-resolution images of soft tissues without ionizing radiation. It excels at identifying small tumors, differentiating between benign and malignant growths, and assessing the tumor’s involvement with blood vessels, making it essential for early diagnosis and treatment planning. Compared to CT and PET scans, MRI provides superior tissue characterization. Its advantages make it a vital tool for pancreatic cancer detection.
Ready to be proactive with your health? Book an Ezra full-body MRI today to detect any issues early and put you on the road to long-term health. Our yearly scan screens for potential cancers early, using AI to enhance the process, making it more efficient and affordable.
1. Canto MI, Harinck F, Hruban RH, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62(3):339-347. doi:10.1136/gutjnl-2012-303108
2. Lee KA, Park KT, Kim WJ, Park TS, Baek HS, Jin HY. Diabetic ketoacidosis as a presenting symptom of complicated pancreatic cancer. Korean J Intern Med. 2014;29(1):116-119. doi:10.3904/kjim.2014.29.1.116
3. MRI - Mayo Clinic. Accessed January 29, 2025. https://www.mayoclinic.org/tests-procedures/mri/about/pac-20384768
4. Berger A. Magnetic resonance imaging. BMJ. 2002;324(7328):35.
5. Costache MI, Costache CA, Dumitrescu CI, et al. Which is the Best Imaging Method in Pancreatic Adenocarcinoma Diagnosis and Staging - CT, MRI or EUS? Curr Health Sci J. 2017;43(2):132-136. doi:10.12865/CHSJ.43.02.05
6. Jin Q, Xie X, Yao H, et al. Clinical Significance of the Radiological Relationship between the Tumor and the main blood vessels in Enneking IIB Osteosarcoma of the extremities. J Cancer. 2020;11(11):3235-3245. doi:10.7150/jca.42341
7. Barral M, Faraoun SA, Fishman EK, et al. Imaging features of rare pancreatic tumors. Diagnostic and Interventional Imaging. 2016;97(12):1259-1273. doi:10.1016/j.diii.2016.07.013
8. Manikkavasakar S, AlObaidy M, Busireddy KK, et al. Magnetic resonance imaging of pancreatitis: An update. World J Gastroenterol. 2014;20(40):14760-14777. doi:10.3748/wjg.v20.i40.14760
9. MRI for Cancer | Magnetic Resonance Imaging Test. Accessed March 14, 2025. https://www.cancer.org/cancer/diagnosis-staging/tests/imaging-tests/mri-for-cancer.html
10. Virostko J. Quantitative Magnetic Resonance Imaging of the Pancreas of Individuals With Diabetes. Front Endocrinol. 2020;11. doi:10.3389/fendo.2020.592349
11. Yang S, Zhang H, Ren X. The application of high-field magnetic resonance perfusion imaging in the diagnosis of pancreatic cancer. Medicine (Baltimore). 2017;96(36):e7571. doi:10.1097/MD.0000000000007571
12. Magnetic Resonance Imaging (MRI and MRCP). Pancreatic Cancer Action Network. Accessed March 14, 2025. https://pancan.org/facing-pancreatic-cancer/diagnosis/magnetic-resonance-imaging-mri/
13. Boekestijn B, Feshtali S, Vasen H, et al. Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions. Fam Cancer. 2024;23(3):295-308. doi:10.1007/s10689-024-00394-z
14. MRI scan - How it’s performed. nhs.uk. September 5, 2018. Accessed March 14, 2025. https://www.nhs.uk/conditions/mri-scan/what-happens/
15. Computed Tomography (CT) Scans and Cancer Fact Sheet - NCI. January 3, 2024. Accessed July 16, 2024. https://www.cancer.gov/about-cancer/diagnosis-staging/ct-scans-fact-sheet
16. PET scan. Accessed March 14, 2025. https://www.cancerresearchuk.org/about-cancer/tests-and-scans/pet-scan
17. Miller FH, Rini NJ, Keppke AL. MRI of Adenocarcinoma of the Pancreas. American Journal of Roentgenology. 2006;187(4):W365-W374. doi:10.2214/AJR.05.0875
18. Xiong C, Xu X, Zhang H, Zeng B. An analysis of clinical values of MRI, CT and X-ray in differentiating benign and malignant bone metastases. Am J Transl Res. 2021;13(6):7335-7341.
19. Pu Y, Wang C, Zhao S, et al. The clinical application of 18F-FDG PET/CT in pancreatic cancer: a narrative review. Transl Cancer Res. 2021;10(7):3560-3575. doi:10.21037/tcr-21-169